Topic
340B
257 published works
Take Stock: Federal Policy Watch
Washington Healthcare Update | May 17, 2021
By Stephanie A. Kennan, McGuireWoods LLP
This week in Washington: HHS and CMS nominations move forward. House Representatives Ask HHS Secretary Becerra to Extend Deadline to Spend COVID-19 Provider Relief Funds In a May 11 letter, 77…
Take Stock: Federal Policy Watch
Washington Healthcare Update | March 8, 2021
This week in Washington: Budget reconciliation goes back to the House with changes for vote on Tuesday. House 340B: 266 House Legislators Want Fines for Drug Companies Two hundred sixty-six members…
Medicaid and the Law
Summary: “Examining HRSA’s Oversight of the 340B Drug Pricing Program” Energy & Commerce Hearing – Oversight and Investigations Subcommittee
WITNESSES Erin Bliss – Assistant Inspector General, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services Debra Draper – Director, Health Care, Government…
Healthcare Law Blog
Contract Pharmacies and the 340B Drug Discount Program: New Litigation and an Advisory Opinion Point to Ongoing Skirmishes on the 340B Battlefield
By Erica Kraus, Theresa Thompson
On December 11, 2020, five hospital groups, including the American Hospital Association (“AHA”), and an organization of hospital pharmacists representing participants in the 340B drug pricing program (“340B Program”), filed…
Medicaid and the Law
The 340B Contract Pharmacy Saga Continues
Hello readers of Medicaid and the Law! First and foremost, we here at the blog would like to wish our readers a very happy and healthy new year. We are…
To Be or Not to 340B Blog
The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback
By Brenda Maloney Shafer, Richard Davis, David Blank
2020 was a tumultuous year for virtually everyone and everything, and the 340B Program was no exception. As we outlined in previous articles, many drug manufacturers have decided that the…
Administrative and Regulatory
The Ten Year Wait is Over: HRSA Releases 340B Dispute Resolution Final Rule
By Kathleen A. Reed, David R. Padalino
The 340B Program, named after its section within the 1992 Public Health Service Act, allows covered entities to stretch their scarce federal resources as far as possible, by setting a…
Homeostasis: Dykema’s Health Care Law Blog
The Ten Year Wait is Over: HRSA Releases 340B Dispute Resolution Final Rule
By Dykema
The 340B Program, named after its section within the 1992 Public Health Service Act, allows covered entities to stretch their scarce federal resources as far as possible, by setting a…
Health Care Law Today
New HHS Board Will Hear 340B Drug Pricing Disputes
By Anil Shankar, Samantha Robbins Jamali, Adam J. Hepworth
On December 14, 2020, HRSA established a long overdue Administrative Dispute Resolution (ADR) process that allows covered entities and drug manufacturers to bring claims against each other related to the…
Health Industry Washington Watch
Long-Awaited issuance of Section 340B ADR final rule
By Joseph W. Metro, James Segroves
In 2010, the Affordable Care Act (ACA) directed the Secretary of Health and Human Services to issue regulations to establish an administrative dispute resolution (ADR) process for certain claims between…